Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy
- Status
- RECRUITING
- Phase
- PHASE3
Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence Risk
- Status
- RECRUITING
- Phase
- PHASE2
Treatment of Advance Gastric Cancer With Disulfiram
- Status
- NOT_YET_RECRUITING
- Phase
- NA
JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
- Status
- RECRUITING
- Phase
- PHASE2
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Novel Treatment Combinations in Patients With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Personalized Medicine for Advanced Biliary Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2